Evidence map›Paper›PMID 37466411›Full record

ReviewJournal of neuroscience research2023

K

Mohammad Asikur Rahman, Razan Orfali, Nikita Dave, Elyn Lam, Nadeen Naguib, Young-Woo Nam, Miao Zhang

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of neuroscience research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Small-Conductance CaNeuroscience bulletin · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mohammad Asikur RahmanDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.
Razan OrfaliDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.ORCID 0000-0002-0584-4013
Nikita DaveDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.
Elyn LamDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.
Nadeen NaguibDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.
Young-Woo NamDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.
Miao ZhangDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.
Chapman University · US

Funding

Development of SK channel modulators as therapeutic agents for ataxiaR33NS101182 · NINDS · CHAPMAN UNIVERSITY · PI BEZPROZVANNY, ILYA B, ZHANG, MIAO · 2021 to 2021
$723k
NINDS NIH HHS R33 NS101182
6 · The paper itself

Abstract

One group of the K

Indexed as

Endothelial CellsPotassium ChannelsAnimalsMembrane PotentialsNeuronsPurkinje CellsRatsPotassium Channelscerebellar ataxiaKCa2.2 channelsmedium afterhyperpolarizationPurkinje cellsspinocerebellar ataxias

Identifiers

PMID37466411
PMCPMC10932612
OpenAlexW4384663195

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.